Synergies for Cancer Treatment

Pages

  • Home
  • Theory
  • Ammonia
  • Synergies
  • Drug Repurposing
  • Spreadsheet
  • GBM
  • TNBC
  • Herbs
  • Forum
  • Reading list
  • FAQ
  • Terms

Pages

  • Warburg Effect
  • Bohr Effect
  • Hoffman Effect
  • Cellular respiration
  • Urea Cycle
  • Cell signalling
  • p53 pathway
  • Diet
  • Safe Use
  • Sitemap
  • About

Cell signalling

 



Hypoxia Signaling
https://www.cellsignal.com/pathways/hypoxia-signaling-pathway

Wnt/β-Catenin Signaling
https://www.cellsignal.com/pathways/wnt-beta-catenin-signaling-pathway

PI3K / Akt Signaling
https://www.cellsignal.com/pathways/pathways-akt-signaling

Notch Signaling
https://www.cellsignal.com/pathways/notch-signaling-pathway

TGF-β Signaling
https://www.cellsignal.com/pathways/tgf-beta-signaling-pathway

GSK3 Signaling {ref}
https://www.thermofisher.com/cl/es/home/life-science/antibodies/antibodies-learning-center/antibodies-resource-library/cell-signaling-pathways/gsk3-signaling-pathway.html

ErbB/HER Signaling
https://www.cellsignal.com/pathways/erbb-her-signaling?_requestid=456880

Molecular Landscapes
Digizyme - Knowledge Through Visual Science
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Home
Subscribe to: Posts (Atom)
  • Drug Repurposing Strategies in Oncology
    Drug Repurposing Drug repurposing involves discovering new uses for existing, clinically approved drugs. This approach offers several key ad...
  • Theory of Cancer
    According to the prevailing accepted theory of carcinogenesis { ref }, the somatic mutation theory, cancer arises when cells acquire many ge...
  • Synergistic Anticancer Effects of Diclofenac and Metformin
    Repurposing non-oncology drugs for cancer treatment has become an area of increasing interest. In particular, combinations of well-known pha...
  • Repurposing Phenylbutyrate: versatile anticancer agent
    Phenylbutyrate (PB), a short-chain fatty acid derivative, is primarily recognized as an ammonia scavenger and histone deacetylase inhibitor ...
  • Combination of RAS(ON) G12C-selective inhibitors with SHP2 inhibitors to sensitize tumours to immune checkpoint blockade
    Lung cancer driven by KRAS mutations, particularly the G12C variant, remains a significant challenge in non-small cell lung cancer (NSCLC) t...

Support unbiased independent cancer research and fuel this blog with a cup of coffee! ☕

Forum - Uncovering the Power of Combined Therapies:

Loading...

Popular Posts

  • Theory of Cancer
    According to the prevailing accepted theory of carcinogenesis { ref }, the somatic mutation theory, cancer arises when cells acquire many ge...
  • Combinations of Natural Products and Repurposed Drugs as Adjunct Cancer Therapy
    Natural supplements can be very helpful adjuvants to drug therapies, for example, through chemosensitization of tumor cells. Unfortunately,...
  • Drug Repurposing Strategies in Oncology
    Drug Repurposing Drug repurposing involves discovering new uses for existing, clinically approved drugs. This approach offers several key ad...
  • The immunomodulatory properties and anticancer effects of disulfiram
    Disulfiram acts as both a direct cytotoxic agent and an immunomodulator, making it a good candidate for combination therapies in cancer trea...
  • Chrysin potentiates the effects of Radiotherapy
    The authors of this study investigated the potential of chrysin, a natural flavonoid, in enhancing radiation therapy (RT)-induced immunogen...
  • Can turmeric enhance radiation therapy for cancer?
    Turmeric and its primary active ingredient, curcumin, have garnered significant interest due to its potential role in augmenting radiation t...
  • Functional Profiling for Cancer
    Functional profiling for cancer is a method used in oncology to assess how cancer cells respond to various drugs or treatments based on the...
  • Review of the Hybrid Orthomolecular Protocol for Cancer Treatment
    The article “ Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol ” introduces a novel ap...
  • Citric acid-mediated ferroptosis strategy
    click to view larger image (created with biorender.com) For further details, please read the forum post . For informational and research pur...
  • Talzenna and Lonsurf for Cancers with TP53 Mutations
     " A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreati...

Featured Post

Metastasis

About 90% of deaths from cancer are a result of metastasis. This article discusses Dr. Dana Pe'er's research on cellular plasticit...

Nature Reviews Cancer

Loading...

Wikipedia

Search results

Blog Archive

Links

  • Khan Academy
  • Perlego
  • Sci-Hub
  • Proton
  • NP Research
  • Archive.org
  • BMC Cancer
  • ESMO
  • Cancer Blogs
  • BioMed News
  • Tumor Biology

Total Pageviews

Subscribe To RSS feed

Posts
Atom
Posts
All Comments
Atom
All Comments

Contact Form

Name

Email *

Message *

Powered By Blogger
© 2016-2025 synergiesforcancertreatments.blogspot.com - A different approach to cancer treatment . Powered by Blogger.